Royal Bank of Canada Lowers Oncolytics Biotech (NASDAQ:ONCY) Price Target to $5.00
Oncolytics Biotech (NASDAQ:ONCY – Get Free Report) had its price objective reduced by equities research analysts at Royal Bank of Canada from $6.00 to $5.00 in a research note issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. A number of other analysts have also issued reports on ONCY. HC […]
Oncolytics Biotech (NASDAQ:ONCY – Get Free Report) had its price objective reduced by equities research analysts at Royal Bank of Canada from $6.00 to $5.00 in a research note issued on Monday,Benzinga reports. The firm currently has an “outperform” rating on the stock. A number of other analysts have also issued reports on ONCY. HC […]
